-
Featured Press Release
During Black History Month Aspira Recognizes the Importance of Bridging the Gap in Ovarian Cancer Risk Assessment Disparities
Learn More -
Investor Event
Aspira to Participate in BTIG’s Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference; Thursday February 18, 2021 9:30am EST
Listen Here
Recent News
Choose a Category:
-
Aspira Women’s Health Inc. Appoints Nicole Sandford to its Board of Directors
Press Release
For a pdf of this press release please click here AUSTIN, Texas — February 22, 2021 — Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced the appointment of Ms. Nicole Sandford to its Board of Directors. “I am very pleased to warmly welcome Nicole to our Board of Directors. She…
-
Aspira Women’s Health Recognizes the Importance of Bridging the Gap in Ovarian Cancer Risk Assessment Disparities During Black History Month
Press Release
For a full pdf of this press release please click here AUSTIN, Texas — February 17, 2021- February is recognized as Black History Month, a time to honor the contributions of Black Americans to culture and society while elevating the voices of those fighting for equity and justice. This month, Aspira Women’s Health Inc. (Nasdaq:…
-
Aspira Women’s Health, Inc. to Participate in BTIG’s Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Press Release
AUSTIN, Texas — February 12, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced management will participate and present in the 2021 BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place on February 17-19. Details for the event are below: BTIG MedTech, Digital Health, Life…
-
Aspira Women’s Health, Inc. to add NCCN Management Recommendations to its Proprietary Aspira GenetiX Clinical Report
Press Release
Aspira will incorporate Management Recommendations from the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in the Aspira GenetiX report. For a pdf of this release please click here AUSTIN, Texas — February 10, 2021 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced they will incorporate…
-
Aspira Women’s Health Inc. Announces Pricing of $45.0 Million Public Offering of Common Stock
Press Release
For a pdf of this press release please click here AUSTIN, Texas, February 4, 2021 – Aspira Women’s Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the pricing of the previously announced underwritten public offering of 6,000,000 shares of its common stock at a price to…
Upcoming Events
-
March 19 – 25, 2021
Virtual Exhibitor
Society of Gynecologic Oncology (SGO) Annual Meeting
-
April 30 – May 2, 2021
Virtual Exhibitor
American College of Obstetrics and Gynecologists Annual Meeting